Since the emergence of nanotechnology, researchers, regulators and the public have been concerned at the potential toxicity of nano-sized products, the U.S. government has an admirably large funding program for the technology, especially in it’s medical application. And though their haven’t been any large scale commercial breakthroughs, nanomedicine battles on to refine the application of molecular nanotechnology.
Much hope is placed in the forward looking researchers who are as we write, furthering their research into the delivery of drugs via nanoscale particles, macromolecules, biopharmaceuticals, flesh welding surgery utilizing gold coated nanoshells, or the visionary field of neuro-electronic interfaces. The uses of nanoparticles in medicine is seemingly endless, except of course for that handicap all foreign objects face when entering the human body; our immune system and it’s antibodies, Nanomedicine it would seem is the way of the future. At any moment a breakthrough is likely to hit the journals, ‘Nanoparticle Targeting Kills Cancer’ until that day though nonomedicine is largely restricted to diagnostic practice. Read the full article »»»»